Issue 9, 2016

An unprecedented case of dodecamorphism: the twelfth polymorph of aripiprazole formed by seeding with its active metabolite

Abstract

A new polymorph of aripiprazole has been discovered, making it the most polymorphic drug to date with twelve reported anhydrous forms, and a record-breaking ninth solved crystal structure. The new form was induced by seeding with crystals of the active metabolite dehydro-aripiprazole.

Graphical abstract: An unprecedented case of dodecamorphism: the twelfth polymorph of aripiprazole formed by seeding with its active metabolite

Supplementary files

Article information

Article type
Communication
Submitted
16 N’w 2015
Accepted
12 Sun 2016
First published
13 Sun 2016

CrystEngComm, 2016,18, 1486-1488

An unprecedented case of dodecamorphism: the twelfth polymorph of aripiprazole formed by seeding with its active metabolite

T. A. Zeidan, J. T. Trotta, P. A. Tilak, M. A. Oliveira, R. A. Chiarella, B. M. Foxman, Ö. Almarsson and M. B. Hickey, CrystEngComm, 2016, 18, 1486 DOI: 10.1039/C5CE02467F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements